Wisconsin officials confirm first measles cases of the year
The Wisconsin DHS said all the cases were exposed to a common source while traveling out of state. They are currently working to notify anyone who may have been exposed to the virus. The DHS says there is no public point of exposure and risk to the community remains low.
Measles is one of the most contagious infectious diseases, and in some cases can cause severe infections in the lungs and brain that can lead to cognitive issues, deafness or death. Symptoms include fever, cough, runny nose, watery eyes and full body rash.
According to the Minnesota Department of Health website, there have been five cases so far this year. In June, a child with measles visited the Mall of America.
The Center of Disease Control released new data on Thursday showing that vaccination coverage for MMR — which includes measles — dropped among kindergartners during the 2024-2025 school year. Vaccinations decreased in more than half of states.
CBS reported in late June that measles cases hit a 30 year high. There was also a confirmed case in New Jersey and a possible outbreak in Colorado.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Lysoway Therapeutics Awarded Grant from The Michael J. Fox Foundation to Advance TRPML1 Agonist to Treat Parkinson's Disease
CAMBRIDGE, Mass., August 06, 2025--(BUSINESS WIRE)--Lysoway Therapeutics, Inc., a biopharmaceutical company developing small molecule modulators of lysosomal ion channels, today announced that it has received a research grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF). Support comes from MJFF's Parkinson's Disease Therapeutics Pipeline Program, which focuses on candidates with strong potential to slow or halt disease progression or alleviate burdensome symptoms for those living with Parkinson's disease. Lysoway Therapeutics funding of $2.93 million will support the preclinical and translational development of Lysoway's novel, highly brain-penetrant small molecule TRPML1 agonist. The study aims to investigate whether activating TRPML1 by a novel, small molecule modulator, will enhance the lysosomal membrane calcium ion channel to restore lysosomal function and help with clearance of alpha-synuclein, the protein that is linked to the disease. "We are honored to receive this generous grant from The Michael J. Fox Foundation," said Valerie Cullen, PhD, Principal Investigator and SVP of Research and Translation at Lysoway. "TRPML1 is a high value target due to its pivotal role in sensing and responding to cellular stress. By activating this ion channel, we can engage multiple beneficial pathways that restore autophagy/lysosomal homeostasis and bolster cellular resilience. Our lead development candidate is both orally bioavailable and highly brain-penetrant, offering strong potential to modify disease progression in Parkinson's Disease." Yongchang Qiu, PhD, Founder and Chief Executive Officer of Lysoway Therapeutics, added "This funding underscores growing confidence in TRPML1 as a compelling target for Parkinson's disease. It will allow us to accelerate development of our lead TRPML1 agonist and to establish key biomarkers for target engagement, with the goal of initiating first-in-human clinical trials early next year." About Lysoway Therapeutics, in Cambridge, MA, Lysoway Therapeutics is a leader in developing therapeutically viable lysosomal ion channel modulators. The company is advancing a pipeline of small molecule activators targeting these channels to treat neurodegenerative diseases. Learn more at View source version on Contacts Media contact: Info@
Axios
30 minutes ago
- Axios
What to know about chikungunya virus, as U.S. travel alerts issued
Chikungunya virus outbreaks have prompted the CDC to issue travel alerts warning U.S. travelers due to an "elevated risk" of exposure to the mosquito-borne illness in China and several other countries. The big picture: At least 240,000 chikungunya cases have been reported in parts of Central and South America, Africa, the Indian Ocean region and Asia this year — with health officials in Guangdong province, South China, confirming 7,000 since June. What are the symptoms of chikungunya virus? The painful viral disease is spread to people by infected female mosquitoes that can also transmit dengue and Zika viruses, per the World Health Organization. "The most common symptoms of chikungunya are fever and joint pain," per the Centers for Disease Control and Prevention. "Other symptoms can include headache, muscle pain, joint swelling, or rash." Which countries has the CDC issued travel alerts for? The CDC has issued level 2 "practice enhanced precautions" chikungunya travel health notices over outbreaks in : Bolivia, South America. Guangdong Province, China. The Indian Ocean region of Madagascar, Mauritius, Mayotte, Réunion, Somalia and Sri Lanka. Of note: The CDC warns of an elevated risk of exposure for U.S. travelers visiting Brazil, Colombia, India, Mexico, Nigeria, Pakistan, the Philippines and Thailand. What's happening in China? Most of the chikungunya illnesses have been reported in Foshan, a Guangdong Province city of about 7.8 million people. The first case was reported in the financial hub of Hong Kong on Monday. Officials have launched a " patriotic public health campaign" in response that the New York Times notes is triggering memories of crackdowns during the COVID pandemic. Zoom in: Foshan crews have been spraying people with insect repellent before letting them in to building entrances, home inspectors have ordered residents to discard stagnant water, per the NYT. Anyone who doesn't comply may be criminally charged for "obstructing the prevention of infectious diseases," and some Guicheng district households have had their power cut. Meanwhile, drones have been launched to detect potential mosquito-breeding sites in sources of stagnant water. Thousands of mosquito-larvae eating fish and cannibal"elephant mosquitoes" that can consume smaller, chikungunya-spreading insects have also been deployed. Is chikungunya common in the U.S.? "Locally acquired chikungunya cases have not been reported from U.S. states or territories since 2019," per the CDC. Yes, but: There were 199 travel-associated reports in the U.S. in 2024 and 46 this year, according to the health agency. What precautions should U.S. travelers take? The CDC level 2 alerts advise travelers to affected regions to take enhanced precautions such as using insect repellent, wearing long-sleeved shirts and pants and staying in places with air conditioning or that have screens on the windows and doors.
UPI
31 minutes ago
- UPI
CDC issues warning as China fights chikungunya virus in Guangdong
1 of 3 | An effort is underway in southern China's Guangdong Province to eradicate the mosquito-borne chikungunya virus. File Photo UPI/Stephen Shaver | License Photo Aug. 5 (UPI) -- U.S. health officials are warning travelers headed to southern China of an outbreak of chikungunya, a disease spread by mosquitos that has spurred a forceful local response. The outbreak has occurred in China's Guangdong Province on the country's southern coast, with most of the cases being reported in the city of Foshan, according to a U.S. Centers for Disease Control and Prevention advisory posted Friday. Fever and joint pain are the most common symptoms of the disease. While most people recover within a week, joint pain can linger for months to years in acute cases, and medically vulnerable people are at greater risk of developing more serious symptoms, the advisory states. The outbreak has prompted Guangdong provincial authorities to launch a "patriotic health campaign" of "clearing water and killing mosquitoes and building a healthy home together." Authorities are calling on households across the country to drain coffee makers, while turning over pots and cans in an effort to eliminate all stagnant water. Since July, more than 7,000 cases have been reported in the province, and in Foshan, patients must remain in the hospital until they test negative or have stayed for a week, reports the BBC. At least a dozen other cities in the region have reported infections, including nearby Hong Kong, reports the news outlet. People purchasing medications to treat chikungunya in Foshan have had to register personal information, reports the South China Morning Post. The virus is not common in China, and the BBC reports that some social media posts have compared the government's response to that of the COVID-19 pandemic, which was criticized as heavy-handed. However, there have been no severe or fatal cases reported and infections are declining, according to the Xinhua news agency. Travelers can prevent chikungunya infections by using insect repellent and wearing long-sleeved shirts and pants, as well as staying indoors in places with air conditioning or screened windows and doors, according to the CDC advisory. Two chikungunya vaccines are approved for use in the United States, and the CDC advises vaccination for travelers who plan to visit an area with an outbreak. The CDC advises pregnant women to avoid areas with outbreaks.
